These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888 [TBL] [Abstract][Full Text] [Related]
23. Novel liver fibrosis model in Macaca fascicularis induced by thioacetamide. Matsuo M; Murata S; Hasegawa S; Hatada Y; Ohtsuka M; Taniguchi H Sci Rep; 2020 Feb; 10(1):2450. PubMed ID: 32051422 [TBL] [Abstract][Full Text] [Related]
24. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice. Hong JS; Lee DH; Yook YW; Na D; Jang YJ; Kim JH; Lee YS Biosci Biotechnol Biochem; 2017 Jul; 81(7):1348-1355. PubMed ID: 28372490 [TBL] [Abstract][Full Text] [Related]
26. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice. Zhou Z; Park S; Kim JW; Zhao J; Lee MY; Choi KC; Lim CW; Kim B Toxicol Mech Methods; 2017 Sep; 27(7):501-510. PubMed ID: 28440100 [TBL] [Abstract][Full Text] [Related]
27. Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice. Bai T; Yang Y; Wu YL; Jiang S; Lee JJ; Lian LH; Nan JX Int Immunopharmacol; 2014 Apr; 19(2):351-7. PubMed ID: 24560906 [TBL] [Abstract][Full Text] [Related]
28. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo. Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857 [TBL] [Abstract][Full Text] [Related]
29. Chlordecone potentiates hepatic fibrosis in chronic liver injury induced by carbon tetrachloride in mice. Tabet E; Genet V; Tiaho F; Lucas-Clerc C; Gelu-Simeon M; Piquet-Pellorce C; Samson M Toxicol Lett; 2016 Jul; 255():1-10. PubMed ID: 26853152 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice. Shu M; Huang DD; Hung ZA; Hu XR; Zhang S Biochem Biophys Res Commun; 2016 Feb; 471(1):233-9. PubMed ID: 26845355 [TBL] [Abstract][Full Text] [Related]
32. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645 [TBL] [Abstract][Full Text] [Related]
33. Alpha-melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. Lee TH; Jawan B; Chou WY; Lu CN; Wu CL; Kuo HM; Concejero AM; Wang CH J Gene Med; 2006 Jun; 8(6):764-72. PubMed ID: 16508911 [TBL] [Abstract][Full Text] [Related]
34. Deficiency of BPOZ2 Decreases Liver Fibrosis After Chronic Carbon Tetrachloride Administration in Mice. Zhang F; Dang S; Shu R; Xiang Y; Kuang Y; Fei J; Wang Z Int J Toxicol; 2015; 34(2):204-10. PubMed ID: 25568138 [TBL] [Abstract][Full Text] [Related]
35. Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats. Sun H; Che QM; Zhao X; Pu XP Eur J Pharmacol; 2010 Apr; 631(1-3):53-60. PubMed ID: 20079350 [TBL] [Abstract][Full Text] [Related]
36. [Hepatic fibrogenesis]. Lee KS Korean J Gastroenterol; 2006 Nov; 48(5):297-305. PubMed ID: 17132917 [TBL] [Abstract][Full Text] [Related]
38. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552 [TBL] [Abstract][Full Text] [Related]
39. Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo. Wang Y; Zhang X; Yang Y; Yang X; Ye B Mar Drugs; 2015 Aug; 13(8):5201-18. PubMed ID: 26295240 [TBL] [Abstract][Full Text] [Related]
40. SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis. Athwal VS; Pritchett J; Llewellyn J; Martin K; Camacho E; Raza SM; Phythian-Adams A; Birchall LJ; Mullan AF; Su K; Pearmain L; Dolman G; Zaitoun AM; Friedman SL; MacDonald A; Irving WL; Guha IN; Hanley NA; Piper Hanley K EMBO Mol Med; 2017 Dec; 9(12):1696-1710. PubMed ID: 29109128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]